← Eichor
Study identifier: NCT04742881 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Low Impact Laparoscopic in Colorectal Resection - PAROS2

Condition: Malignant or Benign Pathology  ·  Sponsor: University Hospital, Bordeaux

PhaseNA
Planned participants148
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To improve post-operative recovery, the concept of Low Impact Laparoscopy was developed in colo-rectal surgery with associating low-pressure pneumoperitoneum and microlaparoscopic surgery. A phase III double-blind, prospective, randomized, controlled, multi-centric trial is designed in the aim to assess the impact of low-pressure pneumoperitoneum with microlaparoscopic instruments on post-operative pain at 24 hours without taking opioids. It is compared with low-pressure laparoscopy with classical laparoscopic instruments in patients undergoing colorectal surgeries.

This description comes directly from the study's public registry record.

Talk to the study team

Christophe LAURENT  ·  +33 (0)5 56 79 58 10  ·  christophe.laurent@chu-bordeaux.fr

Benjamin FERNANDEZ  ·  +33 (0)5 56 79 58 10  ·  benjamin.fernandez@chu-bordeaux.fr

Always discuss trial participation with your own doctor first.

Locations (3)

CH de la Côte BasqueBayonne, FranceRecruiting
CHU BordeauxBordeaux, FranceRecruiting
Ch LibourneLibourne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04742881